DVA
72
2
F
43
-8
GOOG
65
-4
MKC
56
8
DLTR
34
-4
IR
63
3
XYL
37
2
USB
50
2
AXP
66
2
NTAP
64
2
MAS
51
4
ACN
47
-2
VRTX
46
2
TGT
25
-24
TDC
75
4
QRVO
6
2
COST
58
-2
AES
39
-4
VFC
47
-5
BMY
53
-7
DVA
72
2
F
43
-8
GOOG
65
-4
MKC
56
8
DLTR
34
-4
IR
63
3
XYL
37
2
USB
50
2
AXP
66
2
NTAP
64
2
MAS
51
4
ACN
47
-2
VRTX
46
2
TGT
25
-24
TDC
75
4
QRVO
6
2
COST
58
-2
AES
39
-4
VFC
47
-5
BMY
53
-7
Financhill
Back

Akebia Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Buy
59

AKBA
Akebia Therapeutics

Last Price:
1.81
Seasonality Move:
42.93%
Sell
39

LLY
Eli Lilly and

Last Price:
749.91
Seasonality Move:
3.67%
Buy
59
Akebia Therapeutics (AKBA) is a Buy

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.79. The Score for AKBA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • AKBA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy, Sell or Hold?

  • The current Eli Lilly and [LLY] share price is $753.41. The Score for LLY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.79
    The current trend is moderately bullish and AKBA is experiencing slight selling pressure.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

  • The Eli Lilly and share price today is $753.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 55.22 Buy
Chaikin Money Flow: -573816 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.54 - 1.92) Buy
Bollinger Bands (100): (1.2 - 1.66) Buy

LLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -37.99 Sell
Relative Strength Index (14 RSI): 33 Sell
Chaikin Money Flow: 3266793 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (773.88 - 894.52) Sell
Bollinger Bands (100): (825.42 - 941.78) Sell

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.87 Sell
20-day SMA: 1.8 Sell
50-day SMA: 1.54 Buy
200-day SMA: 1.41 Buy
8-day EMA: 1.83 Sell
20-day EMA: 1.77 Buy
50-day EMA: 1.61 Buy
200-day EMA: 1.4 Buy

LLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 775.74 Sell
20-day SMA: 815.11 Sell
50-day SMA: 872.24 Sell
200-day SMA: 834.58 Sell
8-day EMA: 766.92 Sell
20-day EMA: 806.67 Sell
50-day EMA: 849.91 Sell
200-day EMA: 812.36 Sell

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.45 per share.

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):